No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 27 of the 40 quarters in the window, leaving 13 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 2.5x · 10Y median 3.9x · 7th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T15:05:52.497Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Bio Green Med Solution, Inc. (BGMS) stock was $0.85 as of Oct 6, 2026, 11:04 AM EDT, down 2.69% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -81.7%
Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries.
Medical - Pharmaceuticals · Kuala Lumpur, LF
Next Earnings Date
Nov 18, 2026
43 days away
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-43.20
vs Estimate
$-129.60
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BGMS | $4.66M | $0.84 | -2.69% | -81.68% | N/A | N/A | N/A |
| 2LEXX | $4.73M | $2.86 | +3.25% | -78.83% | -50.86% | N/A | vs BGMS |
| 3DRMA | $4.58M | $1.14 | +2.65% | -77.00% | -83.90% | N/A | vs BGMS |
| 4CALC | $4.91M | $1.56 | +1.29% | -90.27% | N/A | N/A | vs BGMS |
| 5CLGN | $4.41M | $3.40 | -0.29% | -85.66% | -53.69% | N/A | vs BGMS |
| 6BMGL | $5.03M | $3.21 | +1.26% | -83.45% | N/A | N/A | vs BGMS |
forward FY estimate
N/A
$336000.00
vs Estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.84
High
N/A
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-268.80 | $-268.80 | $-268.80 | 1 |
| FY 2027 | $880.80 | $880.80 | $880.80 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $100000.00 | $100000.00 | $100000.00 | 1 |
| FY 2027 | $80.58M | $80.58M | $80.58M | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
